MedTrace Logo

Post-operative Crohn's Endoscopic Recurrence Study

NCT00989560 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 175

Last updated 2014-01-13

No results posted yet for this study

Summary

This randomised, controlled study aims to evaluate the impact of endoscopic assessment, and adjustment of therapy, after surgery in patients with Crohn's disease. The primary endpoint is the severity of endoscopic recurrence. In addition, tissue will be collected for microbiological and immunological analysis.

Conditions

Interventions

PROCEDURE

endoscopy

patients receive best treatment and care with an additional endoscopy

Sponsors & Collaborators

Principal Investigators

  • Michael A Kamm, MBBS MD FRCP FRACP · St Vincent's Hospital, Melbourne; University of Melbourne

  • Peter De Cruz, MBBS, FRACP · St Vincent's Hospital, Melbourne; University of Melbourne

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00989560 on ClinicalTrials.gov